Reviva Pharmaceuticals Stock Experiences Wild Swings Following $9 Million Fundraising
Published on 09/23/2025 at 18:18 | Redaktion boerse-global.de
Shares of Reviva Pharmaceuticals Holdings have been on a rollercoaster ride after the company disclosed the completion of a public offering that raised $9 million. The stock plummeted by 39% during Friday’s pre-market trading, only to stage a significant recovery at the start of the week with a gain exceeding 15%.
Financing Details and Market Response
In the offering, Reviva Pharmaceuticals sold 27 million shares priced at $0.335 per share. Each share was issued alongside Series E and Series F warrants. Before accounting for expenses, the gross proceeds to the company total approximately $9 million. These funds are earmarked primarily to support the company’s research and development initiatives. A.G.P./Alliance Global Partners acted as the sole placement agent for the transaction.
The initial, sharp sell-off reflected... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
